IL197602A0 - Compositions and methods to prevent cancer with cupredoxins - Google Patents
Compositions and methods to prevent cancer with cupredoxinsInfo
- Publication number
- IL197602A0 IL197602A0 IL197602A IL19760209A IL197602A0 IL 197602 A0 IL197602 A0 IL 197602A0 IL 197602 A IL197602 A IL 197602A IL 19760209 A IL19760209 A IL 19760209A IL 197602 A0 IL197602 A0 IL 197602A0
- Authority
- IL
- Israel
- Prior art keywords
- cupredoxins
- compositions
- methods
- prevent cancer
- cancer
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84435806P | 2006-09-14 | 2006-09-14 | |
PCT/US2007/078371 WO2008033987A2 (en) | 2006-09-14 | 2007-09-13 | Compositions and methods to prevent cancer with cupredoxins |
Publications (1)
Publication Number | Publication Date |
---|---|
IL197602A0 true IL197602A0 (en) | 2011-08-01 |
Family
ID=39184582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL197602A IL197602A0 (en) | 2006-09-14 | 2009-03-15 | Compositions and methods to prevent cancer with cupredoxins |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2061498A4 (en) |
JP (2) | JP2010503409A (en) |
KR (1) | KR20090059152A (en) |
CN (1) | CN101595124A (en) |
AU (1) | AU2007296429A1 (en) |
BR (1) | BRPI0714987A2 (en) |
CA (1) | CA2663498A1 (en) |
IL (1) | IL197602A0 (en) |
MX (1) | MX2009002787A (en) |
NO (1) | NO20091267L (en) |
RU (1) | RU2009113812A (en) |
SG (1) | SG174784A1 (en) |
WO (1) | WO2008033987A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
UA97466C2 (en) | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Cupredoxin derived transport agents and methods of use thereof |
US9598470B2 (en) | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
BRPI0615562A2 (en) | 2005-07-19 | 2010-01-26 | Univ Illinois | Carriers for crossing the blood-brain barrier and entering brain cancer cells and methods for their use |
EP2089411A4 (en) | 2006-12-04 | 2010-01-27 | Univ Illinois | Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
WO2008098216A2 (en) * | 2007-02-08 | 2008-08-14 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
CA3075836A1 (en) * | 2017-09-29 | 2019-04-04 | Oncgnostics Gmbh | Risk determination for neoplasia and cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
CN1506375A (en) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | Azurin as bacterial protein with wide-spectrum antitumor function and its use and medicinal composition |
UA97466C2 (en) * | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Cupredoxin derived transport agents and methods of use thereof |
WO2007018671A2 (en) * | 2005-05-20 | 2007-02-15 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
MX2008000993A (en) * | 2005-07-19 | 2008-03-19 | Univ Illinois | Compositions and methods to control angiogenesis with cupredoxins. |
-
2007
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/en not_active Application Discontinuation
- 2007-09-13 CA CA002663498A patent/CA2663498A1/en not_active Abandoned
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/en not_active Application Discontinuation
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/en unknown
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/en not_active Application Discontinuation
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/en not_active Withdrawn
- 2007-09-13 EP EP07842403A patent/EP2061498A4/en not_active Withdrawn
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/en active Application Filing
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/en active Pending
-
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/en not_active Application Discontinuation
-
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2061498A2 (en) | 2009-05-27 |
SG174784A1 (en) | 2011-10-28 |
RU2009113812A (en) | 2010-10-20 |
EP2061498A4 (en) | 2009-11-04 |
MX2009002787A (en) | 2009-08-27 |
WO2008033987A3 (en) | 2009-04-30 |
CN101595124A (en) | 2009-12-02 |
NO20091267L (en) | 2009-06-04 |
JP2010503409A (en) | 2010-02-04 |
BRPI0714987A2 (en) | 2013-07-30 |
JP2014050390A (en) | 2014-03-20 |
KR20090059152A (en) | 2009-06-10 |
WO2008033987A2 (en) | 2008-03-20 |
CA2663498A1 (en) | 2008-03-20 |
AU2007296429A1 (en) | 2008-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200905508B (en) | Compositions and methods to prevent cancer with cupredoxins | |
IL197602A0 (en) | Compositions and methods to prevent cancer with cupredoxins | |
ZA201001300B (en) | Antigen-asjuvant compositions and methods | |
IL210153A0 (en) | Nutrigenomics methods and compositions | |
EP2035014A4 (en) | Fucoidan compositions and methods | |
EP2086318A4 (en) | Neuroprotective compositions and methods | |
IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
EP2101731A4 (en) | Endoxifen methods and compositions | |
GB0819530D0 (en) | Methods and compositions | |
EP2315600A4 (en) | Compositions and methods related to sirt1 function | |
GB0721291D0 (en) | Methods and compositions | |
EP2088865A4 (en) | Guggulphospholipid methods and compositions | |
GB0617171D0 (en) | Novel compositions and methods | |
GB0719526D0 (en) | Compositions and methods | |
IL213636A0 (en) | Compositions and methods to prevent cancer with cupredoxins | |
GB0713264D0 (en) | Improvements in and relating to luminaries | |
GB0615609D0 (en) | Uses and compositions comprising miRNAs | |
EP2247303A4 (en) | Haemostasis- modulating compositions and uses therefor | |
EP2061493A4 (en) | Compositions to reduce or prevent skin cancer | |
IL213657A0 (en) | Compositions and methods to prevent cancer with cupredoxins | |
ZA201000357B (en) | 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands | |
EP2059122A4 (en) | Methods and compositions related to apobec-1 expression | |
EP2032146A4 (en) | Methods and compositions related to tr4 | |
GB0811250D0 (en) | Methods and compositions | |
EP2094726A4 (en) | Compositions and methods related to toll-like receptor-3 |